Medical device company Nuvasive have launched a new porous titanium interbody implant for their XLIF procedures, named the Modulus. The Modulus XLIF device is a fully porous device, developed using additive manufacturing technology, otherwise known as 3D-printing.
The new implants provide a “favourable environment for bone in-growth and enhanced visualisation,” says the company. The device utilises a microporous surface topography to construct a titanium interbody that “mimics the porosity and stiffness of bone.”
“Modulus XLIF maximizes the potential of 3D-printed spinal implants through the application of unique and advanced software optimization processes,” says Matt Link, executive vice president of strategy, technology and corporate development at Nuvasive. “This product launch further represents our continued commitment to advancing surgical materials, and delivering best-in-class implants that provide superior osseointegration and biomechanics.”
Surface technology for interbody fusion implants is a growth area for in the spine device industry, with a large number of start-ups, companies and academic institutions hunting for the best ways to optimise bone–device integration.
“Surface architecture is an increasingly important part of the fusion process,” says orthopedic spine surgeon Kade Huntsman (Salt Lake Orthopaedic Clinic, Utah, USA). “The design of Modulus XLIF maximizes the potential of additive manufacturing through the combination of highly porous endplates with an optimized internal structure.”
Nuvasive’s proprietary XLIF procedure is a lateral approach spine procedure supported by 15 years of clinical evidence and hundreds of peer-reviewed publications.
In September, Nuvasive announced the launch of Lessray, a combination software and hardware system that addresses overexposure to harmful radiation in the operating room for surgeons and other medical professions, as well as their patients.
The company will showcase its technologies, including the new Modulus XLIF, at the North American Spine Society (NASS) annual meeting to be held next week, 25–28 October, in Orlando, USA.
